Table 1 Demographic and clinical data between survivors and non-survivors
Survivor (n = 21) | Non-survivor (n = 15) | P | |
|---|---|---|---|
Pre-ECMO demographic data | |||
Age (year) | 37 (26–51) | 35 (27–47) | 0.85 |
Male | 19 (90) | 12 (80) | 0.63 |
ISS | 25 (17–38) | 41 (25–75) | 0.03* |
Traumatic brain injury | 1 (5) | 3 (20) | 0.29 |
MV hours | 14 (6–126) | 26 (9–50) | 0.87 |
Damage control intervention | 13 (62) | 10 (67) | 0.77 |
ER-to-ECMO hours | 21 (9–149) | 37 (14–52) | 0.75 |
Data obtained just before ECMO | |||
pH | 7.29 (7.10–7.40) | 7.20 (6.91–7.32) | 0.14 |
Mean arterial pressure (mmHg)a | 71 (53–92) | 50 (44–59) | 0.01* |
PaO2 (mmHg) | 53 (43–67) | 47 (40–70) | 0.55 |
PaCO2 (mmHg) | 45 (39–70) | 52 (46–87) | 0.19 |
PaO2/FiO2 (mmHg) | 54 (46–67) | 49 (40–83) | 070 |
Peak inspiratory pressure (cmH2O) | 35 (31–38) | 36 (32–48) | 0.21 |
PEEP (cmH2O) | 20 (15–24) | 21 (15–24) | 0.88 |
Hemoglobin (g/dL) | 11 (9–14) | 13 (9–15) | 0.57 |
Platelet count (× 109/L) | 178 (90–199) | 94 (69–190) | 0.28 |
aPTT (second) | 32 (28–41) | 40 (35–62) | 0.04* |
Venovenous ECMO | 16 (76) | 6 (40) | 0.03* |
ECMO-assisted CPR | 2 (10) | 3 (20) | 0.63 |
Complication on ECMO | |||
Major bleeding | 4 (19) | 8 (53) | 0.07 |
Requiring CRRT | 3 (14) | 7 (47) | 0.06 |
Brain event | 4 (19) | 3 (20) | 1.0 |
ECMO hour | 143 (76–219) | 111 (36–297) | 0.47 |
Hospital day | 44 (29–78) | 10 (5–23) | < 0.001* |